AMGN
Price
$286.30
Change
+$4.53 (+1.61%)
Updated
Mar 27, 6:59 PM EST
27 days until earnings call
SNY
Price
$49.54
Change
-$0.21 (-0.42%)
Updated
Mar 27, 6:59 PM EST
28 days until earnings call
Ad is loading...

AMGN vs SNY ᐉ Comparison: Which is Better to Invest?

Header iconAMGN vs SNY Comparison
Open Charts AMGN vs SNYBanner chart's image
Amgen
Price$286.30
Change+$4.53 (+1.61%)
Volume$1.14M
CapitalizationN/A
Sanofi ADS
Price$49.54
Change-$0.21 (-0.42%)
Volume$1.36M
CapitalizationN/A
View a ticker or compare two or three
AMGN vs SNY Comparison Chart

Loading...

AMGNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SNYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
AMGN vs. SNY commentary
Mar 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMGN is a Hold and SNY is a Buy.

COMPARISON
Comparison
Mar 28, 2024
Stock price -- (AMGN: $286.31 vs. SNY: $49.56)
Brand notoriety: AMGN: Notable vs. SNY: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AMGN: 60% vs. SNY: 127%
Market capitalization -- AMGN: $153.44B vs. SNY: $123.51B
AMGN [@Pharmaceuticals: Major] is valued at $153.44B. SNY’s [@Pharmaceuticals: Major] market capitalization is $123.51B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.87B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $87.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMGN’s FA Score shows that 3 FA rating(s) are green whileSNY’s FA Score has 2 green FA rating(s).

  • AMGN’s FA Score: 3 green, 2 red.
  • SNY’s FA Score: 2 green, 3 red.
According to our system of comparison, AMGN is a better buy in the long-term than SNY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMGN’s TA Score shows that 4 TA indicator(s) are bullish while SNY’s TA Score has 5 bullish TA indicator(s).

  • AMGN’s TA Score: 4 bullish, 4 bearish.
  • SNY’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SNY is a better buy in the short-term than AMGN.

Price Growth

AMGN (@Pharmaceuticals: Major) experienced а +4.86% price change this week, while SNY (@Pharmaceuticals: Major) price change was +2.76% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.63%. For the same industry, the average monthly price growth was -2.85%, and the average quarterly price growth was -2.15%.

Reported Earning Dates

AMGN is expected to report earnings on Apr 24, 2024.

SNY is expected to report earnings on Apr 25, 2024.

Industries' Descriptions

@Pharmaceuticals: Major (+0.63% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
A.I.dvisor published
a Summary for AMGN with price predictions.
OPEN
A.I.dvisor published
a Summary for SNY with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
AMGN($153B) has a higher market cap than SNY($124B). AMGN has higher P/E ratio than SNY: AMGN (22.92) vs SNY (21.27). AMGN YTD gains are higher at: 0.180 vs. SNY (-0.342). AMGN has higher annual earnings (EBITDA): 14.8B vs. SNY (12.6B). AMGN has more cash in the bank: 10.9B vs. SNY (8.98B). SNY has less debt than AMGN: SNY (18.4B) vs AMGN (64.6B). SNY has higher revenues than AMGN: SNY (46.4B) vs AMGN (28.2B).
AMGNSNYAMGN / SNY
Capitalization153B124B123%
EBITDA14.8B12.6B117%
Gain YTD0.180-0.342-53%
P/E Ratio22.9221.27108%
Revenue28.2B46.4B61%
Total Cash10.9B8.98B121%
Total Debt64.6B18.4B351%
FUNDAMENTALS RATINGS
AMGN vs SNY: Fundamental Ratings
AMGN
SNY
OUTLOOK RATING
1..100
413
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
6
Undervalued
PROFIT vs RISK RATING
1..100
1337
SMR RATING
1..100
1281
PRICE GROWTH RATING
1..100
5158
P/E GROWTH RATING
1..100
4729
SEASONALITY SCORE
1..100
8527

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNY's Valuation (6) in the Pharmaceuticals Major industry is in the same range as AMGN (17) in the Biotechnology industry. This means that SNY’s stock grew similarly to AMGN’s over the last 12 months.

AMGN's Profit vs Risk Rating (13) in the Biotechnology industry is in the same range as SNY (37) in the Pharmaceuticals Major industry. This means that AMGN’s stock grew similarly to SNY’s over the last 12 months.

AMGN's SMR Rating (12) in the Biotechnology industry is significantly better than the same rating for SNY (81) in the Pharmaceuticals Major industry. This means that AMGN’s stock grew significantly faster than SNY’s over the last 12 months.

AMGN's Price Growth Rating (51) in the Biotechnology industry is in the same range as SNY (58) in the Pharmaceuticals Major industry. This means that AMGN’s stock grew similarly to SNY’s over the last 12 months.

SNY's P/E Growth Rating (29) in the Pharmaceuticals Major industry is in the same range as AMGN (47) in the Biotechnology industry. This means that SNY’s stock grew similarly to AMGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMGNSNY
RSI
ODDS (%)
Bullish Trend 1 day ago
56%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
45%
Bearish Trend 1 day ago
43%
Momentum
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 1 day ago
53%
MACD
ODDS (%)
Bullish Trend 1 day ago
57%
Bullish Trend 7 days ago
46%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
52%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
48%
Bullish Trend 1 day ago
49%
Advances
ODDS (%)
Bullish Trend 1 day ago
57%
Bullish Trend 3 days ago
52%
Declines
ODDS (%)
Bearish Trend 14 days ago
54%
Bearish Trend 10 days ago
43%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
50%
Bearish Trend 1 day ago
47%
Aroon
ODDS (%)
Bearish Trend 1 day ago
46%
Bearish Trend 3 days ago
41%
View a ticker or compare two or three
Ad is loading...
AMGNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SNYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PEBO29.131.05
+3.74%
Peoples Bancorp
FSI1.900.06
+3.26%
Flexible Solutions International
RCL139.722.85
+2.08%
Royal Caribbean Group
WIRE253.194.14
+1.66%
Encore Wire Corp
RLGT5.310.04
+0.76%
Radiant Logistics

AMGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMGN has been loosely correlated with GILD. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if AMGN jumps, then GILD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMGN
1D Price
Change %
AMGN100%
+1.61%
GILD - AMGN
44%
Loosely correlated
+0.83%
JNJ - AMGN
36%
Loosely correlated
+1.41%
BIIB - AMGN
33%
Loosely correlated
+2.03%
BMY - AMGN
33%
Poorly correlated
+1.33%
ABBV - AMGN
32%
Poorly correlated
+0.65%
More

SNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNY has been loosely correlated with NVS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if SNY jumps, then NVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNY
1D Price
Change %
SNY100%
-0.38%
NVS - SNY
38%
Loosely correlated
+0.64%
GSK - SNY
34%
Loosely correlated
+0.47%
GILD - SNY
32%
Poorly correlated
+0.83%
BMY - SNY
31%
Poorly correlated
+1.33%
AZN - SNY
30%
Poorly correlated
+2.89%
More